Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab in Early-stage Multiple Primary Lung Cancer with GGNs
NCT04026841Phase 2Unknown
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Jul 2019
- Primary completion
- Feb 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in multiple primary lung cancer (MPLC), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Status: unknown.
02
Drugs
sintilimab
03
Conditions
multiple primary lung cancer (MPLC)
Beyond the preview
Go deeper on NCT04026841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04026841.